ALPN Insider Trading Activity and SEC Form 4 Filings
ALPN insider trading summary
No open-market insider purchases or sales of Alpine Immune Sciences, Inc. (ALPN) have been reported on SEC Form 4 in the past 12 months.
Latest ALPN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 25, 2024 | James N Topper | Insider | Sell | $1K (19 @ $64.57) |
| Jan 26, 2024 | James Paul Rickey | See Remarks | Sell | $1.1M (44,000 @ $25.00) |
| Jan 26, 2024 | James Paul Rickey | See Remarks | Sell | $1.6M (73,764 @ $22.31) |
| Jan 25, 2024 | James Paul Rickey | See Remarks | Sell | $5K (236 @ $22.00) |
| Dec 28, 2023 | OrbiMed Capital GP VI LLC | Director | Sell | $21.9M (1,195,683 @ $18.32) |
| Dec 28, 2023 | OrbiMed Capital GP VI LLC | Director | Sell | $62K (3,128 @ $19.82) |
| Dec 28, 2023 | Orbimed Advisors LLC | Director | Sell | $21.9M (1,195,683 @ $18.32) |
| Dec 28, 2023 | OrbiMed Genesis GP LLC | Director | Sell | $533K (26,872 @ $19.82) |
| Dec 28, 2023 | Orbimed Advisors LLC | Director | Sell | $533K (26,872 @ $19.82) |
| Dec 28, 2023 | Orbimed Advisors LLC | Director | Sell | $62K (3,128 @ $19.82) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.